Lite Strategy, Inc. — Investor Relations & Filings

Lite Strategy, Inc. is a publicly traded company that has adopted Litecoin (LTC) as its primary treasury reserve asset. The company's core strategy involves accumulating and holding pure LTC through active treasury management, with the stated objective of increasing LTC exposure per share for its shareholders. This model provides public market investors with a vehicle for institutional exposure to the digital asset. Formerly known as MEI Pharma, Inc., a clinical-stage oncology company, the corporation rebranded and pivoted its business model in 2025 to focus on its Litecoin treasury operations.